Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug interactions: concerns and current approaches.

Alaa-Eldin F Nassar1, Rasmy E Talaat, Hajime Tokuno

  • 1Vion Pharmaceuticals Inc, 4 Science Park, New Haven, CT 06511, USA. nassaral@aol.com

Idrugs : the Investigational Drugs Journal
|December 26, 2006
PubMed
Summary

Predicting metabolic drug interactions early in drug discovery is crucial for safety and market success. Early evaluation prevents costly withdrawals and protects public health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spinal Cord Stimulator Explant and Revision Complicated by Syrinx Formation: A Case Report and Literature Review.

Cureus·2019
Same author

Use of Digital Infrared Thermal Imaging in the Electromyography Clinic: A Case Series.

Cureus·2019
Same author

Biotransformation and Rearrangement of Laromustine.

Drug metabolism and disposition: the biological fate of chemicals·2016
Same author

Pharmacotherapy for Pain in a Family With Inherited Erythromelalgia Guided by Genomic Analysis and Functional Profiling.

JAMA neurology·2016
Same author

Exploring a clinically friendly web-based approach to clinical decision support linked to the electronic health record: design philosophy, prototype implementation, and framework for assessment.

JMIR medical informatics·2015
Same author

Metabolite identification in rat brain microdialysates by direct infusion nanoelectrospray ionization after desalting on a ZipTip and LTQ/Orbitrap mass spectrometry.

Rapid communications in mass spectrometry : RCM·2009

Area of Science:

  • Pharmacology
  • Drug Development
  • Toxicology

Background:

  • Recent drug withdrawals highlight the risks of metabolic drug-drug interactions.
  • Drug safety is a major focus for regulatory bodies and the pharmaceutical industry.
  • Animal models have limitations in predicting human drug responses.

Purpose of the Study:

  • To emphasize the importance of early prediction of drug interactions in drug discovery.
  • To discuss strategies for evaluating a drug candidate's potential for drug interactions.
  • To address the legal, regulatory, and commercial implications of drug safety.

Main Methods:

  • Review of drug withdrawal data (1964-1999).
  • Discussion of challenges in predicting human drug responses from animal models.
  • Exploration of strategies for assessing drug interaction potential.

Main Results:

  • Approximately 8% of FDA-approved drugs were withdrawn between 1964 and 1999.
  • Inadequate safety evaluation during drug optimization can lead to market withdrawal.
  • Drug safety issues have significant economic and public relations consequences.

Conclusions:

  • Early identification of drug interaction potential is vital for successful drug development.
  • Proactive safety assessment mitigates risks to human health and the pharmaceutical industry.
  • Implementing robust evaluation strategies is essential for ensuring drug safety and market longevity.

Related Experiment Videos